1. World Health Organization. Diarrhoeal disease fact sheet, 2022
2. GBD 2017 Diarrhoeal Diseases Collaborators. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Bur-
den of Disease Study 2015 , Lancet Infect Dis. 2020;20(2):174-183.
3. Guerrant RL, et al. Tropical Infectious Diseases. Guerrant RL, Walker DH, Weller PF (eds), Saunders; 2011.
4. Keely SJ and Barrett KE, Intestinal secretory mechanisms and diarrhea, Am J Physilogy Gastrointest Liver Physiol 322; G405-G420, 2022
5. Onul B. İnfeksiyon Hastalıkları. Ankara Üniversitesi Basımevi, Ankara, 1980: 772.
6. Sack DA. Cholera and related illnesses caused by Vibrio, Aeromonas, and Plesiomonas species. In: Gorbach SL, Bartlett JG, Blacklow NR (eds). Infectious Diseases 4th ed. Philadelphia: Lip-
pincott Williams & Wilkins; 2004: 661-6
7. Menon MP, Mintz ED, Tauxe RV. Cholera. In: Brachman PS, Abrutyn E (eds). Bacterial Infections of Humans: Epidemiology and Control 4th ed. New York: Plenum Medical Book Company;
2009: 249-272.
8. Waldor MK, Ryan ET. Vibrio cholerae. In: Bennett JE, Dolin R, Blaser MJ (eds). Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. 8th ed. Philadelphia: Saunders;
2015: 2741-2479.
9. Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. Cholera. Lancet 2012;379(9835): 2466-2476.
10. Sack DA, Sack B, Siddique AK. Cholera. Lancet 2004;363: 223-233.
11. Onul B. Türkiye Sınırlarına Ulaşan Epidemi: Kolera. Güzel İstanbul Matbaası, Ankara, 1966.
12. Aktaş F. Kolera: Ülkemizdeki durum. In: Eraksoy H, Yenen O.Ş (yazarlar). 5. Ulusal İnfeksiyon Hastalıkları Kongre Kitabı İstanbul: Ana Basım San. ve Tic. AŞ; 1995: 15.
13. Blake PA. Epidemiology of cholera in Americas. Gastroenterol Clin North Am. 1993; 22: 639-660.
14. Mandal BK. Epidemic cholera due to a novel strain of V. cholerae non-01-the beginning of a new pandemic. J Infect 1993; 27: 115-117.
15. Ramamurthy T, Garg S, Sharma R, Bhattacharya SK, Nair GB, Shimada T, et al. Emergence of novel strain of Vibrio cholerae non-O1 in Bangladesh. Lancet 1993;341: 703-704.
16. Deen J,Mengel MA, Clemens JD. Epidemiology of cholera. Vaccine 38 2020 A31-A40
17. Guerrant RL. Lessons from diarrheal diseases: Demography to Molecular Pharmacology. J Infect Dis. 1994; 169: 1206-1218.
18. Ali M, Lopez AL, You YA, Kim YE, Sah B, Maskery B, Clemens J. The global burden of cholera. Bull World Health Organ 2012;90: 209- 218A.
19. Akyay N. Türkiye’de ilk kolera yayınları. Türk Hij Tec Biyol Derg. 1974; 33: 129.
20. Tezok F, Birol K, Koçer A, Meriç N. 1970 İstanbul kolerasının nedenleri ve koleraya genel bir bakış. Mikrobiyoloji Bült 1970; 4: 1.
21. Gün H. Kolera: Türkiye’de güncel durum. In: Eraksoy H, Yenen OŞ eds. 5. Ulusal İnfeksiyon Hastalıkları Kongre Kitabı İstanbul: Ana Basım San. ve Tic. AŞ; 1995: 13.
22. Doğancı L, Gün H, Baysallar M, Albay A, Çınar E, Haznedaroğlu T. Short-term quinolones for successful eradication of multiple resistant Vibrio cholerae in adult patients. Scand J Infect Dis.
1995; 27: 425-426.
23. De Schrijver K, Boeckx H, Top G, Mertens A, De Mol P. Cholera in Belgian tourists after travel to Turkey. Euro Surveill 2005;10: E051012.2.
24. Abbott SL, Janda JM, Farmer III JJ. Vibrio and related organisms. Eds: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW eds. In: Manual of Clinical Microbiology.
10th ed. Washington DC: American Society for Microbiology; 2011: 666-676.
25. Alam M, Sultana M, Nair GB, et al. Viable but nonculturable Vibrio cholerae O1 in biofilms in the aquatic environment and their role in cholera transmission. Proc Natl Acad Sci USA
2007;104:17801-17806.
26. Karaolis DKR, Lan R, Reeves PR. The sixth and seventh cholera pandemics are due to independent clones seperately derived from environmental, nontoxigenic, non-O1 Vibrio cholarae. J
Bacteriology 1995; 177: 3191-3198.
27. Faruque SM, Islam MJ, Ahmad QS, Faruque AS, Sack DA, Nair GB, et al. Self-limiting nature of seasonal cholera epidemics: Role of hostmediated amplification of phage. Proc Natl Acad Sci
USA 2005;102: 6119-6124.
28. Faruque SM, Naser IB, Islam MJ, Faruque AS, Ghosh AN, Nair GB, et al. Seasonal epidemics of cholera inversely correlate with prevelance of environmental cholera pages. Proc Natl Acad Sci
USA 2005;102: 1702-1707.
29. Hartley DM, Morris JG, Smith DL. Hyperinfectivity: a critical element in the ability of V. cholerae to cause epidemics? PLoS Med 2006;3: e7.
30. Harris JB, LaRocque RC, Charles RC, Mazumder RN, Khan AI, Bard- han PK. Cholera’s western front. Lancet 2010;376:1961-1965.
31. Koelle K, Rodo X, Pascual M, Yunus M, Mostafa G. Refractory periods and climate forcing in cholera dynamics. Nature 2005;436: 696- 700.
32. Willke A, Arman D, Tolunay C. Vibrio cholerae El-Tor suşlarının çeşitli antibiyotiklere duyarlılıklarının araştırılması. Mikrobiyol Bült. 1988; 22: 101-104.
33. Pasetti MF, Levine MM. Insights from natural infectionderived immunity to cholera instruct vaccine efforts. Clin Vaccine Immunol 2012;19: 1707-1711.
34. Johnson RA, Uddin T, Aktar A, Mohasin M, Alam MM, Chowdhury F, et al. Comparison of immune responsesto teh O-spesific polysaccharide and lipopolysaccharide of Vibrio cholerae O1
in Bangladeshi adult patients with cholera. Clin Vaccine Immunol 2012;19: 1712-1721.
35. Patel SM; Rahman MA, Mohasin M, Riyadh MA, Leung DT, Alam MM, et al. Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection
from house-hold contacts of patients with cholera in Bangladesh. Clin Vaccine Immunol 2012;19: 842-848.
36. Weil AA, Khan AI, Chowdhury F, LaRocque RC, Faruque AS, Ryan ET, et al. Clinical outcomes in household contacts of patients with cholera in Bangladesh. Clin Infect Dis 2009;49: 1473-
1479.
37. Azman AS, Rudolph KE, Cummings DAT, Lessler J. The incubation period of cholera: A systematic review. J Infect 2013;66: 432-438.
38. Ryan ET, Dhar U, Khan WA, Salam MA, Faruque AS, Fuchs GJ, et al. Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh. Am J Trop
Med Hyg 2000; 63:12-20.
39. Ciglenecki I, Bichet M, Tena J, Mondesir E, Bastard M, Tran NT, et al. Cholera in pregnancy: Outcomes from a specialized cholera treatment unit for pregnant women in Léogâne, Haiti. PLoS
Ngl Trop Dis 2013, 7:e2368
40. World Health Organization. The Treatment of Diarrhoea, a Manual for Physicians and Other Senior Health Workers. 4th Revision, 2005. http://whqlibdoc.who.int/publica- ti-
ons/2005/9241593180.
41. Koleranın (Vibrio cholerae enfeksiyonu) Mikrobiyolojik Tanısı. Akbaş E, Abacıoğlu H, Ötgün SN (Yazarlar). Ulusal Mikrobiyoloji Stan- dartları: Bulaşıcı Hastalıklaboratuvar Tanı Rehberi,
Cilt 1. Tür- kiye Halk Sağlığı Kurumu, Sağlık Bakanlığı Yayın No: 934. Ankara, 2014: B-MT-12: 1-29.Erişim Tarihi 1 Mart 2015. http://mikrobiyoloji.thsk.saglik.gov.tr/Dosya/ tani rehberi/
UMS-Cilt-1.
42. Cholera https://www.cdc.gov/cholera/prevention/cholera-vaccines.html, May, 2024
43. Hahn S, Kim Y, Garner P. Reduced osmolarity oral rehydration solution for treating dehydration due to diarrhoea in children: systematic review. BMJ 2001;323: 81-85.
44. Alam NH, Yunus M, Faruque ASG, Gyr N, Sattar S, Parvin S, et al. Symptomatic hyponatremia during treatment of dehydrating diarrheal disease with reduced osmolarity oral rehydration
solution. JAMA 2006;296: 567-573.
45. Leibovici-Weissmann Y, Neuberger A, Bitterman R, Sinclair D, Sa- lam MA, Paul M. Antimicrobial drugs for treating cholera. Cochrane Database Syst Rev 2014;6: CD008625.
46. Kitaoka M, Miyata ST, Unterweger D, Pukatzki S. Antibiotic resistance mechanisms of Vibrio cholerae. J Med Microbiol 2011;60:397-407.
47. Willke A, Altay G, Tulunay FC, Ertuğrul N. Comparative in vitro activity of 4 new quinolones and 8 other antibiotics against V. cholerae, Shigella spp. In: Selected Proceedings from the
International Congress for Infectious Diseases, Rio de Janeiro, Brazil, April 17-21, 1988. Excerpta Medica; 1988: 65.
48. Altay G, Willke A, Arman D, Tulunay FC. Ofloxacin in cholera. In: Selected Proceedings from the International Congress for Infectious Diseases, Rio de Janeiro, Brazil, April 17-21, 1988.
Excerpta Medica; 1988: 10.
49. Usubütün S, Ağalar C, Diri C, Türkyılmaz R. Single dose ciprofloxacin in cholera. Eur J Emerg Med 1997; 4:145-149.
50. World Health Organization Global Task Force on Cholera Control. Prevention and Control of Cholera Outbreaks: WHO Policy and Recommendations. 2011:2011 Erişim Tarihi 1 Mart 2015.
http://www. who.int/cholera/prevention_control/en/
51. World Health Organization Global Task Force on Cholera Control. First steps for managing an outbreak of acute diarrhoea. 2010:2010. Erişim Tarihi 1 Mart 2015. http://whqlibdoc.who.int/
hq/2010/WHO_CDS_CSR_NCS_2003.7_ Rev.2_eng.
52. Cholera https://www.cdc.gov/cholera/prevention/cholera-vaccines.html, May, 2024